ES2119178T3 - Composiciones terapeuticas conteniendo un compuesto de litio y silice. - Google Patents

Composiciones terapeuticas conteniendo un compuesto de litio y silice.

Info

Publication number
ES2119178T3
ES2119178T3 ES94909190T ES94909190T ES2119178T3 ES 2119178 T3 ES2119178 T3 ES 2119178T3 ES 94909190 T ES94909190 T ES 94909190T ES 94909190 T ES94909190 T ES 94909190T ES 2119178 T3 ES2119178 T3 ES 2119178T3
Authority
ES
Spain
Prior art keywords
lithium
composite
silice
therapeutic compositions
vesicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94909190T
Other languages
English (en)
Inventor
James Derek Birchall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keele University
Original Assignee
Keele University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB939305040A priority Critical patent/GB9305040D0/en
Priority to GB939324360A priority patent/GB9324360D0/en
Application filed by Keele University filed Critical Keele University
Application granted granted Critical
Publication of ES2119178T3 publication Critical patent/ES2119178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Abstract

UNA COMPOSICION TERAPEUTICA PARA EL TRATAMIENTO DE INFECCIONES CUTANEAS INDUCIDAS POR VIRUS COMPRENDE UN PRIMER MATERIAL PARA BLOQUEAR LA DUPLICACION DE ADN VIRAL Y UN SEGUNDO MATERIAL FINAMENTE DIVIDIDO QUE ABSORBE EL FLUIDO EXUDADO DE VESICULAS. UNAS COMPOSICIONES PREFERIDAS COMPRENDE UN COMPUESTO DE LITIO (COMO EL MATERIAL PARA BLOQUEAR LA DUPLICACION DE ADN VIRAL) Y SILICE (COMO EL MATERIAL PARA ABSORBER EL FLUIDO EXUDADO DE VESICULAS). UN EJEMPLO DE COMPOSICION DE ACUERDO CON LA INVENCION COMPRENDE UN COMPUESTO DE LITIO DISUELTO O SUSPENDIDO EN UNA SAL DE SILICE ACUOSA.
ES94909190T 1993-03-12 1994-03-11 Composiciones terapeuticas conteniendo un compuesto de litio y silice. Expired - Lifetime ES2119178T3 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB939305040A GB9305040D0 (en) 1993-03-12 1993-03-12 Preparation for the treatment of virus-induced cutaneous infections
GB939324360A GB9324360D0 (en) 1993-11-26 1993-11-26 Therapeutic compositions

Publications (1)

Publication Number Publication Date
ES2119178T3 true ES2119178T3 (es) 1998-10-01

Family

ID=26302572

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94909190T Expired - Lifetime ES2119178T3 (es) 1993-03-12 1994-03-11 Composiciones terapeuticas conteniendo un compuesto de litio y silice.

Country Status (11)

Country Link
US (1) US5814347A (es)
EP (1) EP0688222B1 (es)
JP (1) JPH08507513A (es)
AT (1) AT165975T (es)
AU (1) AU681629B2 (es)
CA (1) CA2158137C (es)
DE (1) DE69410248T2 (es)
DK (1) DK0688222T3 (es)
ES (1) ES2119178T3 (es)
GR (1) GR3027644T3 (es)
WO (1) WO1994020119A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783424B1 (fr) * 1998-09-03 2002-10-04 Labcatal Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique
EP1242096B1 (en) * 1999-12-30 2005-10-12 Henderson Morley Research and Development Limited Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639625A (en) * 1967-07-13 1972-02-01 Lewis Sherwin Compositions containing lithium succinate
DE2215728C3 (es) * 1972-03-30 1979-02-15 Stickl, Helmut, Prof. Dr.Med., 8033 Krailling
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
FR2590642B1 (fr) * 1985-11-22 1989-02-10 Carton Ste Continentale Ondule Robinet distributeur amovible pour conteneur de liquide

Also Published As

Publication number Publication date
JPH08507513A (ja) 1996-08-13
DK688222T3 (es)
CA2158137A1 (en) 1994-09-15
CA2158137C (en) 2004-03-02
AU681629B2 (en) 1997-09-04
EP0688222B1 (en) 1998-05-13
US5814347A (en) 1998-09-29
AU6212294A (en) 1994-09-26
DE69410248T2 (de) 1999-01-21
EP0688222A1 (en) 1995-12-27
WO1994020119A1 (en) 1994-09-15
DK0688222T3 (da) 1999-03-01
GR3027644T3 (en) 1998-11-30
DE69410248D1 (de) 1998-06-18
AT165975T (de) 1998-05-15

Similar Documents

Publication Publication Date Title
ES2107538T3 (es) Agentes de contraste de ultrasonidos inorganicos porosos.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
ES2157994T3 (es) Inhibidores tetra y pentapeptidos sustituidos de la proteina farnesiltransferasa.
FR2616796B1 (fr) Compositions liquides non aqueuses de traitement des tissus et de blanchissage, comprenant une argile organophile, paquet de detergent de blanchissage a usage unique, et articles detergents unitaires de blanchissage les contenant
ES2146774T3 (es) Polimeros de ioneno que contienen aniones biologicamente activos.
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
RU94031126A (ru) Циклические мочевины и их аналоги, пригодные в качестве ингибиторов протеазы ретровирусов, способ лечения вирусных инфекций, фармацевтическая композиция
KR880012631A (ko) 데스아자푸린- 누클레오시드 유도체, 이들의 제조방법, 이들을 함유하는 제학적 조성물, 헥산 배열을 위한 이들의 용도 그리고 안티바이러스제로서 이들의 용도
PT97638A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
ES8304800A1 (es) "procedimiento de preparacion de una composicion terapeutica en la que el unico agente hemostatico activado efectivo sea el factor viia".
BR8401940A (pt) Composto,processo para preparacao do mesmo,composicao,processo para evitar ou exterminar insetos e uso do dito composto
BR0215216A (pt) Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii
IL63712A (en) Composition for the treatment of osteitis comprising an aqueous gel of cross-linked fibrous proteins
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
ES2146600T3 (es) Condroitinasa, procedimiento para su preparacion y composicion farmaceutica.
DE59403818D1 (de) Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
AU3284984A (en) Pharmaceutical compositions for the transdermal application of active ingredients
DE69406440T2 (de) Arzneimittelzusammensetzung für verabreichung von nikotin durch die nase
EP0431129A4 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
DE69317537T2 (de) Antiallergische Zusammensetzung zur ophthalmischen oder nasalen Anwendung
BR9714059A (pt) S-omeprazol em uma forma neutra, processo para preparar o mesmo, uso deste, composição farmacêutica, e, processo para tratar uma condição relacionada com ácido gástrico.
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
DK246587D0 (da) 1-aralkylpyrazoler, fremgangsmaader til deres fremstilling og anvendelse til bekaempelse af skadelige organismer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 688222

Country of ref document: ES